CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 217 filers reported holding CHEMOCENTRYX INC in Q3 2022. The put-call ratio across all filers is 0.77 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $17,000 | +112.5% | 335 | 0.0% | 0.00% | +200.0% |
| Q2 2022 | $8,000 | 0.0% | 335 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $8,000 | -33.3% | 335 | 0.0% | 0.00% | -50.0% |
| Q4 2021 | $12,000 | +100.0% | 335 | 0.0% | 0.00% | +100.0% |
| Q3 2021 | $6,000 | +50.0% | 335 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $4,000 | +33.3% | 335 | +520.4% | 0.00% | 0.0% |
| Q1 2021 | $3,000 | – | 54 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 296,327 | $7,429,000 | 2.90% |
| Integral Health Asset Management, LLC | 400,000 | $10,028,000 | 2.61% |
| Cormorant Asset Management, LP | 865,000 | $21,686,000 | 1.66% |
| HealthCor Management, L.P. | 956,740 | $23,985,000 | 1.60% |
| Sofinnova Investments, Inc. | 573,684 | $14,382,000 | 1.09% |
| Lisanti Capital Growth, LLC | 321,569 | $8,062,000 | 0.91% |
| Cahill Wealth Management, LLC | 44,913 | $1,125,000 | 0.84% |
| Perceptive Advisors | 1,655,079 | $41,493,000 | 0.83% |
| RA Capital Management | 1,155,964 | $28,980,000 | 0.63% |
| Avidity Partners Management LP | 1,175,000 | $29,457,000 | 0.61% |